Earnings History Data for Ardelyx, Inc. (ARDX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Ardelyx, Inc.

Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase II clinical trials for the treatment of patients with ESRD-HD and chronic kidney disease, as well as for constipation-predominant irritable bowel syndrome. Ardelyx, Inc. is headquartered in Fremont, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
31-10-2024	AH		ARDX	Ardelyx, Inc.	1,410	N/A	-0.05	0.03	Ardelyx GAAP EPS of $0.00 beats by $0.05, revenue of $98.24M beats by $11.6M [10/31/2024 4:07 PM]	6.05	0.18 (3.07%)	5.99	0.12 (2.04%)	3.43 - 10.13	6,934,145	2,820,000	345,749
Ardelyx GAAP EPS of $0.00 beats by $0.05, revenue of $98.24M beats by $11.6M [10/31/2024 4:07 PM] Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update [2024-10-31 04:02PM] Ardelyx: Q3 Earnings Snapshot [2024-10-31 04:22PM] Compared to Estimates, Ardelyx (ARDX) Q3 Earnings: A Look at Key Metrics [2024-10-31 05:30PM] Ardelyx (ARDX) Reports Break-Even Earnings for Q3 [2024-10-31 05:15PM] Ardelyx Inc (ARDX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amidst ... [2024-11-01 03:18AM] Q3 2024 Ardelyx Inc Earnings Call [2024-11-01 10:04AM]
01-08-2024	AH		ARDX	Ardelyx, Inc.	1,290	-0.07	-0.10	-0.08	Ardelyx GAAP EPS of -$0.07 beats by $0.03, revenue of $73.22M beats by $18.19M [8/1/2024 4:10 PM]	6.03	0.53 (9.55%)	5.65	0.15 (2.73%)	3.16 - 10.13	9,525,548	3,890,000	569,381
Ardelyx GAAP EPS of -$0.07 beats by $0.03, revenue of $73.22M beats by $18.19M [8/1/2024 4:10 PM]
02-05-2024	AH		ARDX	Ardelyx, Inc.	1,500	-0.11	-0.13	-0.13	Ardelyx GAAP EPS of -$0.11 beats by $0.04, revenue of $46.02M beats by $9.63M [5/2/2024 4:33 PM]	8.74	1.95 (28.79%)	8.19	1.40 (20.62%)	3.16 - 10.13	21,450,305	5,330,000	1,468,102
Ardelyx up 13% on quarterly results beat [5/2/2024 5:38 PM] Ardelyx GAAP EPS of -$0.11 beats by $0.04, revenue of $46.02M beats by $9.63M [5/2/2024 4:33 PM]
22-02-2024	AH		ARDX	Ardelyx, Inc.	2,100	-0.12	-0.09	0.06	Ardelyx GAAP EPS of -$0.12 misses by $0.02, revenue of $34.36M beats by $0.14M [2/22/2024 4:03 PM]	8.66	-0.16 (-1.76%)	8.20	-0.62 (-7.03%)	2.82 - 10.13	9,743,060	6,110,000	439,230
Ardelyx GAAP EPS of -$0.12 misses by $0.02, revenue of $34.36M beats by $0.14M [2/22/2024 4:03 PM] Ardelyx down 8% after hours as Q4 bottom line disappoints [2/22/2024 4:41 PM]
31-10-2023	PM		ARDX	Ardelyx, Inc.	784.31	0.03	-0.11	-0.14	Ardelyx GAAP EPS of $0.03 beats by $0.14, revenue of $56.4M beats by $33.83M [10/31/2023 7:32 AM]	3.94	0.32 (8.91%)	3.80	0.18 (4.97%)	1.16 - 5.12	13,555,623	11,910,000	670,310
Ardelyx Q3 2023 Earnings Preview [10/30/2023 11:34 AM] Ardelyx GAAP EPS of $0.03 beats by $0.14, revenue of $56.4M beats by $33.83M [10/31/2023 7:32 AM] Ardelyx gains as Ibsrela drives strong Q3 beat [10/31/2023 2:29 PM]
02-08-2023	PM		ARDX	Ardelyx, Inc.	844.98	-0.08	-0.12	-0.19	Ardelyx GAAP EPS of -$0.08 beats by $0.04, revenue of $22.3M beats by $7.02M [8/2/2023 7:20 AM]	4.05	0.21 (5.47%)	4.02	0.18 (4.69%)	0.66 - 5.12	9,330,807	3,010,000	317,584
Ardelyx Q2 2023 Earnings Preview [8/1/2023 1:41 PM] Ardelyx GAAP EPS of -$0.08 beats by $0.04, revenue of $22.3M beats by $7.02M [8/2/2023 7:20 AM]
03-05-2023	AH	4:00 PM ET (May 3)	ARDX	Ardelyx, Inc.	960.19	-0.13	-0.11	-0.21	Ardelyx GAAP EPS of -$0.13 misses by $0.03, revenue of $11.4M beats by $0.99M [5/3/2023 4:18 PM]	4.71	0.03 (0.53%)	4.40	-0.28 (-5.98%)	0.49 - 5.12	6,859,667	4,460,000	179,437
Ardelyx GAAP EPS of -$0.13 misses by $0.03, revenue of $11.4M beats by $0.99M [5/3/2023 4:18 PM]
02-03-2023	AH	4:00 PM ET (Mar 2)	ARDX	Ardelyx, Inc.	585.80	0.06	0.01	-0.31	Ardelyx GAAP EPS of $0.06 beats by $0.07, revenue of $44.18M beats by $21M [3/2/2023 4:03 PM]	3.82	0.93 (32.18%)	3.38	0.49 (16.96%)	0.49 - 3.98	49,470,738	4,760,000	2,760,662
Ardelyx GAAP EPS of $0.06 beats by $0.07, revenue of $44.18M beats by $21M [3/2/2023 4:03 PM] Ardelyx up 9% as biopharma's Q4 2022 results beat on top and bottom lines [3/2/2023 5:27 PM] Ardelyx adds 16% as Wedbush upgrades after Q4 earnings [3/3/2023 9:17 AM]
03-11-2022	AH	4:00 PM ET (Nov 3)	ARDX	Ardelyx, Inc.	242.78	-0.14	-0.17	-0.42	Ardelyx GAAP EPS of -$0.14 beats by $0.03, revenue of $4.99M beats by $1.07M [11/3/2022 4:15 PM]	1.49	0.01 (0.34%)	1.45	-0.03 (-2.03%)	0.49 - 1.92	2,711,316	2,600,000	15,967
Ardelyx GAAP EPS of -$0.14 beats by $0.03, revenue of $4.99M beats by $1.07M [11/3/2022 4:15 PM] Ardelyx, Inc. Reports Employment Inducement Grants [Nov-02-22 04:01PM] Ardelyx Reports Third Quarter 2022 Financial Results and Recent Business Highlights [Nov-03-22 04:01PM] Ardelyx Presents New Data Analyses at Kidney Week 2022, Further Supporting the Clinical Relevance of XPHOZAH® (tenapanor), an Investigational, Phosphate Absorption Inhibitor to Control Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis [Nov-03-22 10:00AM] Ardelyx (ARDX) Reports Q3 Loss, Tops Revenue Estimates [Nov-03-22 05:25PM]
04-08-2022	AH	4:00 PM ET (Aug 4)	ARDX	Ardelyx, Inc.	100.63	-0.19	-0.19	-0.45	Ardelyx GAAP EPS of -$0.19 in-line, revenue of $2.53M beats by $0.31M [8/4/2022 4:08 PM]	0.8530	0.03 (4.02%)	0.77	-0.05 (-6.10%)	0.49 - 1.92	2,298,653	1,220,000	87,490
Ardelyx GAAP EPS of -$0.19 in-line, revenue of $2.53M beats by $0.31M [8/4/2022 4:08 PM] Ardelyx Reports Second Quarter 2022 Financial Results and Recent Business Highlights [Aug-04-22 04:01PM] Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates [Aug-04-22 06:25PM]
05-05-2022	AH	4:00 PM ET (May 5)	ARDX	Ardelyx, Inc.	109.21	-0.21	-0.20	-0.34	Ardelyx GAAP EPS of -$0.21 in-line, revenue of $0.47M misses by $0.41M [5/5/2022 4:27 PM]	0.8039	-0.03 (-4.01%)	0.82	-0.02 (-2.09%)	0.58 - 8.25	2,957,794	6,860,000	126,481
Ardelyx GAAP EPS of -$0.21 in-line, revenue of $0.47M misses by $0.41M [5/5/2022 4:27 PM] Ardelyx Reports First Quarter 2022 Financial Results and Recent Business Highlights [May-05-22 04:01PM] Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates [May-05-22 05:35PM]
28-02-2022	AH	4:00 PM ET (Feb 28)	ARDX	Ardelyx, Inc.	79.94	-0.31	-0.25	-0.32	Ardelyx GAAP EPS of -$0.31 misses by $0.05, revenue of $1M beats by $0.12M [2/28/2022 4:07 PM]	0.7378	-0.03 (-4.18%)	0.72	-0.05 (-6.49%)	0.58 - 9.23	2,936,642	1,960,000	110,574
Ardelyx GAAP EPS of -$0.31 misses by $0.05, revenue of $1M beats by $0.12M [2/28/2022 4:07 PM] Ardelyx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights [Feb-28-22 04:01PM] Ardelyx (ARDX) Reports Q4 Loss, Misses Revenue Estimates [Feb-28-22 05:55PM]
12-11-2021	PM		ARDX	Ardelyx, Inc.	121.68	-0.42	-0.34	-0.20	Ardelyx EPS misses by $0.09, misses on revenue [11/12/2021 8:34 AM]	1.12	-0.04 (-3.88%)	1.15	-0.01 (-0.86%)	1.01 - 9.23	2,198,279	3,060,000	83,165
Ardelyx EPS misses by $0.09, misses on revenue [11/12/2021 8:34 AM] Is a Surprise Coming for Ardelyx (ARDX) This Earnings Season? [Nov-10-21 10:53AM] Ardelyx to Present at the Jefferies London Healthcare Conference [Nov-11-21 04:05PM] Ardelyx Reports Third Quarter 2021 Financial Results [Nov-12-21 08:00AM]
13-08-2021	PM		ARDX	Ardelyx, Inc.	157.93	-0.45	-0.36	-0.28	Ardelyx EPS misses by $0.09, beats on revenue [8/13/2021 8:26 AM]	1.44	-0.08 (-5.26%)	1.56	0.04 (2.63%)	1.43 - 9.23	4,650,117	18,510,000	390,551
Ardelyx EPS misses by $0.09, beats on revenue [8/13/2021 8:26 AM] Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CarLotz, Ardelyx, and Activision Blizzard and Encourages Investors to Contact the Firm [Aug-11-21 08:00PM] SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ardelyx, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 28, 2021 - ARDX [Aug-11-21 07:23PM] Ardelyx Inc. Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Ardelyx Inc. [Aug-11-21 05:55PM] ARDX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 28, 2021 in the Class Action Filed on Behalf of Ardelyx, Inc. Limited Shareholders [Aug-11-21 01:48PM] INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ardelyx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-11-21 12:20PM] Lawsuits Filed Against OCGN, CRMD and ARDX - Jakubowitz Law Pursues Shareholders Claims [Aug-11-21 12:10PM] SHAREHOLDER ALERT: Robbins LLP Announces that Ardelyx Inc. (ARDX) is Being Sued for Misleading Shareholders [Aug-11-21 11:28AM] SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ardelyx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-11-21 11:19AM] ARDX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ardelyx, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm [Aug-11-21 11:00AM] ARDX ALERT - Shareholder Rights Firm Labaton Sucharow is Investigating Ardelyx, Inc. (NASDAQ:ARDX) for Potential Securities Violations and Breach of Fiduciary Duty [Aug-11-21 11:00AM] ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ARDX [Aug-11-21 09:40PM] SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX [Aug-11-21 10:23PM] ARDX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Ardelyx, Inc. [Aug-12-21 05:26AM] SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Ardelyx, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 28, 2021 - (ARDX) [Aug-12-21 11:33AM] SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ardelyx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-12-21 11:30AM] SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ardelyx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-12-21 11:45AM] ARDX Lawsuit Filed: Jakubowitz Law Pursues Claims on Behalf of Ardelyx, Inc. Shareholders [Aug-12-21 01:14PM] Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Ardelyx, Inc. (ARDX) [Aug-12-21 01:30PM] Pomerantz Law Firm Announces the Filing of a Class Action Against Ardelyx, Inc. and Certain Officers - ARDX [Aug-12-21 06:10PM] Robbins Geller Rudman & Dowd LLP Announces Opportunity for Investors with Substantial Losses to Lead the Ardelyx Inc. Class Action Lawsuit ARDX [Aug-12-21 08:02PM] ARDX CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Ardelyx Inc. Shareholders of Securities Fraud Class Action Lawsuit [Aug-12-21 08:25PM] INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ardelyx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-12-21 11:05PM] CLASS ACTION UPDATE for LOTZ, OTLY and ARDX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Aug-13-21 05:40AM] Ardelyx Reports Second Quarter 2021 Financial Results [Aug-13-21 08:00AM] ARDX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ardelyx, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm [Aug-13-21 10:00AM] The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AHCO, ARDX and CXO [Aug-13-21 10:30AM] Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates [Aug-13-21 09:45AM] SHAREHOLDER ALERT: RKT ARDX ZY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines [Aug-13-21 07:30PM] ARDX INVESTOR NEWS: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action ARDX [Aug-13-21 06:15PM] Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Ardelyx Inc. of Securities Class Action Lawsuit [Aug-13-21 04:29PM] SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadline ARDX [Aug-13-21 07:50PM]
06-05-2021	PM	8:00 AM ET (May 6)	ARDX	Ardelyx, Inc.	666.09	-0.34	-0.31	-0.25	Ardelyx EPS misses by $0.01, beats on revenue [5/6/2021 8:46 AM]	6.62	-0.09 (-1.41%)	6.62	0.0 (0.00%)	4.96 - 9.23	1,506,369	3,400,000	34,569
Ardelyx EPS misses by $0.01, beats on revenue [5/6/2021 8:46 AM] Ardelyx Reports First Quarter 2021 Financial Results and Recent Business Highlights [May-06-21 08:00AM] Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates [May-06-21 09:35AM]
08-03-2021	PM	8:00 AM ET (Mar 8)	ARDX	Ardelyx, Inc.	582.10	-0.32	-0.26	-0.28	Ardelyx EPS misses by $0.06, beats on revenue [3/8/2021 9:16 AM]	6.28	-0.39 (-5.88%)	6.68	0.01 (0.15%)	4.22 - 8.33	888,138	888,486	5,868
Ardelyx EPS misses by $0.06, beats on revenue [3/8/2021 9:16 AM] Ardelyx (ARDX) Reports Q4 Loss, Misses Revenue Estimates [Mar-08-21 09:25AM] Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights [Mar-08-21 08:00AM]
05-11-2020	PM		ARDX	Ardelyx, Inc.	462.64	-0.20	-0.28	-0.37	Ardelyx EPS beats by $0.08, beats on revenue [11/5/2020 8:19 AM]	5.73	0.37 (6.90%)	5.73	0.0 (0.00%)	4.22 - 8.82	448,606	415,736	16,874